Anti-CARD8 antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | CARD8 |
| Immunogen: | KLH conjugated synthetic peptide derived from human CARD8 221-320/431 |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:400-1:2000) |
| Reactivity: | Human |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Concentration: | 1mg/ml |
| Purity: | Protein A/G affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | Apoptotic protein NDPP 1 |
| Apoptotic protein NDPP1 | |
| CARD 8 | |
| CARD inhibitor of NF kappa B activating ligand | |
| CARD inhibitor of NF kappaB activating ligand | |
| CARD inhibitor of NF kappaB activating ligands | |
| CARD-inhibitor of NF-kappa-B-activating ligand | |
| CARD8 | |
| CARD8_HUMAN | |
| CARDINAL | |
| Caspase recruitment domain containing protein 8 | |
| Caspase recruitment domain family member 8 | |
| Caspase recruitment domain protein 8 | |
| Caspase recruitment domain-containing protein 8 | |
| DACAR | |
| NDPP 1 | |
| NDPP1 | |
| TUCAN | |
| Tumor up regulated CARD containing antagonist of CASP9 | |
| Tumor up regulated CARD containing antagonist of caspase 9 | |
| Tumor up-regulated CARD-containing antagonist of CASP9 |
Show More
Target information
Inhibits NF-kappa-B activation. May participate in a regulatory mechanism that coordinates cellular responses controlled by NF-kappa-B transcription factor. May be a component of the inflammasome, a protein complex which also includes PYCARD, NALP2 and CASP1 and whose function would be the activation of proinflammatory caspases.
Provider
Erpantech Laboratory
